| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_220502f4465d0df4f6e058e25e45d626
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5330ad500605ea29067c0f6a45bb65f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0038 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2011-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b217ca02153407c901acc06da754cf4 |
| publicationDate |
2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8226946-B2 |
| titleOfInvention |
Enhancement of light activated therapy by immune augmentation using anti-CTLA-4 antibody |
| abstract |
The efficacy of light activated therapy treatment is enhanced by stimulating the immune system of the patient substantially above a normal level. Abnormal tissue that is destroyed by the light activated therapy releases factors that stimulate the immune system, leading to systemic reductions in abnormal tissue (i.e., reduction beyond the region treated using light). By further stimulating the immune system using an anti-CTLA-4 antibody, the systemic destruction of abnormal tissue is enhanced. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612669-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10155818-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10836830-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10829559-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10800849-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11458220-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015184099-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11447557-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11425905-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11529153-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017165742-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10280226-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017165778-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10577426-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3498295-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11401335-B2 |
| priorityDate |
2008-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |